CAMP4 Conference: Korro, Tevard Spotlight RNA Fixes for Genetic DiseaseMarketBeat · 5 days ago
CAMP4 to Participate in Chardan's 10th Annual Healthcare ConferenceGlobeNewsWire · Oct 14, 2026
CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Stock Rated “Moderate Buy” by Wall Street BrokeragesDefense World · Sep 30, 2026
CAMP4 Targets Q4 ASCEND Trial Start for SYNGAP1 Therapy CMP-002Defense World · Sep 29, 2026
Camp4 Therapeutics Corporation (CAMP) Analyst/Investor Day TranscriptSeeking Alpha · Sep 28, 2026
CAMP4 Targets Q4 ASCEND Trial Start for SYNGAP1 Therapy CMP-002MarketBeat · Sep 28, 2026CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.